Whole-body Cryotherapy for Fatigue in ME/CFS, Fibromyalgia, Long COVID
Official title: Whole-body Cryotherapy in Those With Chronic Fatigue: A Feasibility Study
Run by Oxford Brookes University · NCT07874217 · Data updated 2026-11-12
This study tests whether brief, repeated exposure to extreme cold can help reduce fatigue and related symptoms in adults with ME/CFS, fibromyalgia, or Long COVID compared to healthy controls.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Oxford Brookes University Academic / other |
| Locations | 1 site (Oxford, Oxon) |
| Status | Recruiting |
| Started | October 5, 2026 |
| Main results expected | January 8, 2027 |
| Study ends | January 8, 2027 |
| Registry record updated | November 5, 2026 |
| Trial ID | NCT07874217 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 with ME/CFS, fibromyalgia, Long COVID, or healthy controls willing to undergo multiple cryotherapy sessions.
✕Probably not a fit
Patients unable to tolerate cold exposure or with contraindications to cryotherapy may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot feasibility study will enroll 40 adults (18–65 years) across four groups: healthy controls and individuals with ME/CFS, fibromyalgia, or Long COVID. Participants will undergo ten cryotherapy sessions over two weeks to assess tolerability, adherence, and the practicality of collecting outcome measures. The study aims to gather initial signals on symptom changes and inform future larger trials. The approach focuses on potential biological mechanisms such as autonomic balance, vascular function, inflammation, and cellular energy processes. No efficacy conclusions will be drawn from this small feasibility cohort.
Why it matters
Potential benefit: If successful, WBCT could offer a non-drug option to help manage fatigue and related symptoms in these conditions.
How similar studies have gone: Preliminary work in ME/CFS and related conditions suggests potential reductions in fatigue and improvements in autonomic regulation with cryotherapy, but this area is still exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * The study will recruit 40 adult participants (aged 18-65 years) divided across four groups: 10 healthy controls, 10 individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), 10 individuals with Fibromyalgia, and 10 individuals with Long COVID. The relatively small group size is appropriate for a pilot feasibility study, where the primary aim is to assess recruitment, retention, tolerability of the intervention, and the practicality of completing the proposed outcome measures. The sample size reflects the exploratory nature of the study, current resource availability and funding, and the intensive intervention schedule requiring ten visits over a two-week period. In addition, there is limited UK-based evidence regarding participant responses to whole-body cryotherapy within these clinical populations, further supporting a cautious, feasibility-focused sample size. Exclusion Criteria: * The primary physical risks relate to exposure to extreme cold during whole-body cryotherapy and minor discomfort associated with blood sampling. To mitigate these risks, all participants will undergo a structured medical screening using a standard WBCT medical questionnaire to identify contraindications (e.g. uncontrolled hypertension, cardiovascular disease, circulatory disorders such as Raynaud's disease, cryoglobulinaemia, severe respiratory disease, or claustrophobia). Individuals meeting exclusion criteria will not be enrolled.
Where it's running
-
Oxford Brookes University - Centre for Movement, Occupation and Rehabilitation Sciences (MOReS)
Oxford, Oxon, United Kingdom Recruiting
Study contacts
- Study coordinator: Patrick Esser
- Email: pesser@brookes.ac.uk
- Phone: +44 (0) 1865 534881
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
A platform for collecting health data on ME/CFS and Long Covid
This study is trying to collect health information from adults with ME/CFS and Long Covid to help researchers better understand these conditions and improve future treatments.
-
Improving life for patients with chronic fatigue syndrome
This study is testing if two medications can help people aged 18-65 with chronic fatigue syndrome feel better and manage their symptoms.
-
Fatigue Investigation Using Digital Outcomes
This study tests whether digital monitoring with a smartphone app and wearables can track fatigue in people with MS or long COVID, compared with healthy volunteers.
-
Biomarker study to understand Long COVID using VIPER
This study tests biomarkers in people with Long COVID and those who recovered from COVID-19 to see how they can diagnose and track the condition over time.
-
PERCEIVE-Outreach: A scalable care model to help people with Long COVID manage heart and lung symptoms
This study tests a remote care model to see if a personalized, telehealth-based exercise program helps adults with Long COVID feel better and move more.
-
Noninvasive brain stimulation to see if it lowers pain in fibromyalgia
This study tests whether daily noninvasive brain stimulation can reduce pain and improve quality of life for people with fibromyalgia, using two brain targets and a crossover design.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.